Skip to main content

Advertisement

Table 2 Adverse and severe adverse events of OA patients after Re-Join® and HA treatment (n = 52)

From: Treatment of knee osteoarthritis with intra-articular injection of autologous adipose-derived mesenchymal progenitor cells: a prospective, randomized, double-blind, active-controlled, phase IIb clinical trial

Group Number of patients Number of injections AEs, n SAEs, n Frequency of AE (%) Frequency of SAEs (%) P value
HA 26 104 14 1 53.85 3.846 0.1144
Re-Join@ 26 103 19 0 73.07 0  
Total 52 207 33 1 63.46 1.92  
  1. AE adverse event, SAE serious adverse events